Header Logo

Connection

ERIC JONASCH to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications ERIC JONASCH has written about Clinical Trials, Phase III as Topic.
ERIC JONASCH
Connection Strength
0.251
Clinical Trials, Phase III as Topic
  1. Exposure-response modeling of cabozantinib in patients with renal cell carcinoma: Implications for patient care. Cancer Treat Rev. 2020 Sep; 89:102062.
    View in: PubMed
    Score: 0.162
  2. Axitinib in the treatment of metastatic renal cell carcinoma. Future Oncol. 2011 Nov; 7(11):1247-53.
    View in: PubMed
    Score: 0.089
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.